Iq Eq Fund Management (Ireland) LTD Crispr Therapeutics Ag Transaction History
Iq Eq Fund Management (Ireland) LTD
- $831 Million
- Q4 2024
A detailed history of Iq Eq Fund Management (Ireland) LTD transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Iq Eq Fund Management (Ireland) LTD holds 36,264 shares of CRSP stock, worth $1.55 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
36,264
Previous 13,617
166.31%
Holding current value
$1.55 Million
Previous $639,000
123.32%
% of portfolio
0.17%
Previous 0.07%
Shares
3 transactions
Others Institutions Holding CRSP
# of Institutions
488Shares Held
64.1MCall Options Held
1.64MPut Options Held
1.93M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.97MShares$382 Million3.09% of portfolio
-
Capital International Investors Los Angeles, CA8.74MShares$373 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.81MShares$162 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$118 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.75MShares$117 Million1.21% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.32B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....